Awards & Advancement

Protagonist Therapeutics names chief scientific officer

Friday, June 7, 2013 02:11 PM

Protagonist Therapeutics has appointed David Y. Liu, Ph.D., chief scientific officer. With 26 years of biotechnology industry experience, Liu is a former vice president of research and a corporate officer at FibroGen with knowledge and expertise in the fields of inflammation and fibrosis.

More... »

Kite Pharma names chief medical officer

Friday, June 7, 2013 02:10 PM

Kite Pharma, a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT) products for cancer, has appointed Keith Nolop, M.D., chief medical officer. Nolop, with 20 years of drug development experience at both biotechnology and global pharmaceutical companies, was previously senior vice president of development and chief medical officer at Plexxikon.

More... »

Chiltern promotes Alecia Barbee to VP, Global Biometrics

Tuesday, June 4, 2013 12:00 PM

Global CRO Chiltern International has promoted Alecia Barbee to VP, Global Biometrics.

More... »

Armada names EVP of industry relations & advocacy

Monday, June 3, 2013 04:10 PM

Armada Health Care, a group purchasing and channel management organization for the specialty pharmacy market, has appointed Mike Baldzicki—EVP of industry relations & advocacy.

More... »

Avillion appoints Ramani Varanasi chief business officer

Thursday, May 30, 2013 01:24 PM

Avillion, which focuses on clinical co-development of therapeutics, has expanded its leadership team, appointing Ramani Varanasi, MSc, MBA, chief business officer.

Varanasi has 18 years of biotechnology and pharmaceutical industry experience  in structuring, negotiating and executing successful strategic alliances, licensing agreements and M&A transactions, as well as in business development, management and strategic leadership.

More... »

Icon names Dr. Neil McCullough executive vice president

Thursday, May 30, 2013 01:18 PM

Global CRO Icon has appointed Dr. Neil McCullough executive vice president of quality and compliance and corporate training. McCullough will provide strategic direction for quality management, quality assurance and corporate training across all Icon lines of business, ensuring Icon continues to deliver high-quality solutions to clients that are fully compliant with the evolving global regulations guiding the biopharmaceutical industry.

More... »

Johannes Schubmehl appointed CIO of Bayer HealthCare

Friday, May 24, 2013 11:31 AM

Bayer HealthCare, a global healthcare company, has appointed Johannes Schubmehl as chief information officer (CIO). Schubmehl succeeds Matthias Moritz, who had left the company at the end of March.

More... »

Greenphire CEO selected as finalist in Ernst & Young Entrepreneur of the Year Awards

Wednesday, May 22, 2013 08:00 AM

Greenphire, a of payment technologies for the clinical trials industry, announced that the company's CEO, Sam Whitaker, has been selected as a finalist for the Ernst & Young Entrepreneur of the Year Awards 2013 in the Greater Philadelphia region.

More... »

PPD earns award for innovation in training and development

Monday, May 20, 2013 08:00 AM

Pharmaceutical Product Development (PPD), a global CRO, has been named by Skillsoft as a winner of the 2013 Skillsoft Perspectives Innovation Award for Empowering Learning Cultures in the Enterprise.

More... »

Regenesis Biomedical names Scott Brooks as CEO

Friday, May 17, 2013 11:28 AM

The board of directors of Regenesis Biomedical, a privately held medical technology company focused on tissue regeneration, has unanimously elected Scott Brooks as the next chief executive officer and member of the board of directors, succeeding Virginia Rybski. Brooks will assume his new role immediately.

More... »